5.16
09.59 (01.86%)
As of Mar 06, 2024
Bioventus Inc [BVS]
As of Mar 12, 2024 | Source: Annual Report to the SEC
Company Overview
Bioventus Inc is a global medical device company focused on developing and commercializing clinically differentiated, cost efficient and minimally invasive treatments that engage and enhance the body’s natural healing process.
| Country | United States |
| Headquarters | Durham, North Carolina |
| Phone Number | (919) 474-6700 |
| Industry | Measuring, Analyzing, And Controlling Instruments; Photographic, Medical And Optical Goods; Watches And Clocks |
| Employees | 970 |
| CEO | Robert E. Claypoole |
| Website | www.bioventus.com |
Recent Stories
Bioventus and Misonix stockholders approve the acquisition of Misonix by Bioventus
Picture Credit : Newsday Bioventus Inc. [BVS] (“Bioventus” or the “Company”), a global leader in innovations for active healing, and Misonix, Inc.[MSON] (“Misonix”), a provider of minimally invasive ...
Financial Overview
| Revenue | 512,345 K |
| Operating Revenue | -81,725 K |
| Profits | -195,625 K |
| Net Cash | 5,127 K |
Management Effectiveness
| Return on Equity | -88.47% |
| Return on Assets | -24.12% |
| Turnover Ratio | 0.47 K |
| EBITDA | -72,883 K |
Profit Ratios
| Gross Margin | 328,193 K |
| Operating Margin | -15.95% |
| Profit as % of Revenues | -167.77% |
| Profit as % of Assets | -17.92% |
| Profit as % of Stockholder Equity | -88.47% |
Balance Sheet and Cash Flow Measures
| Total Assets | 810,910 K |
| Total Liabilities | 589,792 K |
| Operating Cash Flow | 15,344 K |
| Investing Cash Flow | 15,807 K |
| Financing Cash Flow | -26,653 K |